AM

AB Magnitude Ventures Group

North America, New Jersey, United States, Morristown

Description

AB Magnitude Ventures Group is an investment firm.

Investor Profile

AB Magnitude Ventures Group has backed more than 5 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Pre Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Series A (40%)
  • Series C (20%)
  • Pre Seed (20%)
  • Seed (20%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Oncology
  • Medical
  • Artificial Intelligence (Ai)
  • Information Services
  • Saas
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AB Magnitude Ventures Group frequently co-invest with?

AC
North America, New York, United States, New York
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Catalio Capital Management
North America, New York, United States, New York
Co-Investments: 1
General Catalyst
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Global BioAccess Fund
North America, New York, United States, New York
Co-Investments: 1
CV
North America, Massachusetts, United States, Boston
Co-Investments: 1
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 1
BlackMars Capital
Europe, Sachsen-Anhalt, Germany, Hessen
Co-Investments: 1
Colt Ventures
North America, Texas, United States, Dallas
Co-Investments: 1
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by AB Magnitude Ventures Group?

ArrePath

Princeton, New Jersey, United States

ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.

BiotechnologyHealth CareMedical
SeedJun 23, 2025
Myrobalan Therapeutics

Medford, Massachusetts, United States

Myrobalan Therapeutics is a biotech firm that develops oral neurorestorative therapies to reverse key brain dysfunctions and CNS conditions.

BiotechnologyHealth CareTherapeutics
Series AJan 10, 2024
Amount Raised: $24,000,000
Odyssey Therapeutics

Cambridge, Massachusetts, United States

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

BiotechnologyHealth CareOncologyTherapeutics
Series CDec 5, 2023
Amount Raised: $101,000,000
Oloren AI

San Diego, California, United States

Oloren AI offers molecular descriptor that leverages informations from millions of publically curated datasets.

Artificial Intelligence (AI)Information ServicesSaaSSoftware
Pre SeedAug 31, 2022
Amount Raised: $300,000
BAKX Therapeutics

Kingston, New York, United States

BAKX Therapeutics is a provider of cancer treatment.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series ANov 18, 2021
Amount Raised: $25,000,000